The Mount Sinai Department of Neurosurgery
The Department of Neurosurgery at the Mount Sinai Health System, established in 1914, has gained a distinguished international reputation. Its areas of expertise include:
- Brain tumors, both benign and malignant
- Minimally invasive treatment of Skull-base lesions
- Deep Brain Stimulation for movement disorders and psychiatric disorders
- Pituitary and neuroendocrine disorders
- Cerebrovascular disorders
- Spinal cord injury and disorders
- Traumatic Brain Injury
Mount Sinai Brain Tumor Program
The Department of Neurosurgery provides comprehensive care to patients with peripheral and central nervous system tumors as well as to those with neurological complications of systemic cancer. Our physicians employ the most advanced evaluation, diagnosis, and treatment techniques available, including computer-assisted, image-guided tumor resections and biopsies, advanced skull-base approaches, and minimally invasive endoscopic procedures. We also offer enrollment in clinical trials.
Our highly advanced, stereotactic radiosurgery program gives patients a treatment option that does not require open surgery, and some patients may qualify for gene therapy. Our interdisciplinary approach means members of the neurology, radiation oncology, and rehabilitation medicine departments work together to develop the best treatment plan for each patient.
The Skull Base and Cranial Base Surgery Program
This multidisciplinary center provides innovative treatments for lesions of nerve, blood vessel, and brain located in the complex structures and remote recesses at the base of the skull. Specialists in neurosurgery, otolaryngology, head and neck cancer, craniofacial surgery, oral and maxillofacial surgery, and microvascular and reconstructive procedures apply their expertise to achieve optimum results.
Our surgeons and physicians have pioneered the development of minimally invasive techniques, including purely endoscopic tumor resection and stereotactic radiosurgery to treat complex skull-base lesions. Our program is world renowned for the treatment of pituitary adenomas, acoustic neuromas, and meningiomas.
The center also offers expertise in the related fields of neurology, electrophysiology, pathology, radiation oncology, rehabilitation medicine, and medical oncology.
Clinical Program for Cerebrovascular Disorders and Stroke
Our team evaluates each patient to determine the appropriate treatment for cerebrovascular conditions and vascular lesions. Conditions we treat include:
- Intracranial aneurysms
- Arteriovenous malformations of the brain, dura, and spinal cord
- Carotid artery stenosis
- Intracerebral hemorrhage
- Stroke/cerebral infarction
- Lesions of the skull base
- Trigeminal neuralgia
Center for Neuromodulation
Our neurosurgeons employ the latest technologies, such as deep brain stimulation, to target the locations of brain and spinal cord abnormalities. We also focus on developing minimally invasive neurosurgical techniques that may modulate neural function, replace lost neuronal populations, or halt the neurodegenerative process altogether.
Mount Sinai performs the largest number of deep brain stimulation procedures for the treatment of Parkinson’s disease, dystonia, Tourette’s and essential tremor in the Northeast. The Dystonia Medical Research Foundation has honored our physicians for their pioneering work in treating dystonia with deep brain stimulation.
Mount Sinai Program for Stereotactic Neurosurgery
This program has extended the scope of operative tumors by using such techniques as:
- Frame-based or frameless stereotaxy
- Awake and asleep brain mapping
- Endoscopic surgery
Our physicians remain pioneers in computer-assisted techniques. The development of a precision navigation system and the addition of the Novalis® Shaped Beam Surgery system at Mount Sinai have substantially reduced wound and neurosurgical morbidity, length of surgery, length of stay, and hospital costs.
Our team of neurosurgery spine surgeons specialize in the treatment of spine diseases and disorders, including:
- Degenerative disorders, such as disc herniation, spinal stenosis, and spinal instability
- Spine Trauma
- Congenital disorders, including scoliosis
- Tumors of the spine and spinal cord
Our neurosurgeons have pioneered endoscopic, minimally invasive surgical approaches to treat disorders of the spine. These approaches may reduce postoperative pain, speed recovery, shorten hospital stays, reduce disability, and facilitate an early return to daily routine while providing the same or improved decompression or stabilization.
The Mount Sinai neurosurgery department is a leading expert in the treatment of meningiomas, non-cancerous tumors of the meningies. Our neurosurgeons use the following approaches for the treatment of meningiomas:
- Stereotactic radiosurgery
- Endoscopic-assisted approaches
The treatment of critically ill neurosurgical and neurological patients is handled by our expert neurointensivists in our Neurosceince Intensive Care Unit. Opened in 1990, our NSICU is one of only three in the New York City area which is run by a UCNS board certified neuro-intensivist.
The Department of Neurosurgery is home to research initiatives which include:
- Neurosurgical Simulation
- Gene therapy
- Stem cell research
- Deep brain stimulation
- Minimally invasive approaches to the skull base.
- Spinal cord injury
The financial support we receive from the National Institutes of Health, other grants, and private donations enables our faculty to publish their findings in areas that include neurosimulation, stem cell research, deep brain stimulation and spinal cord injury. The collaboration between our research and clinical teams allows us to turn research findings into new therapies and better approaches to patient care.
The Department of Neurosurgery has educational opportunities for students of all levels, including high school, college, medical students, residents and fellows.
At the Mount Sinai Department of Neurosurgery, our seven year residency program is accredited by the Accreditation Council for Graduate Medical Education and is one of the most competitive in the country.
The Neurocritical Care Fellowship is lead by Errol Gordon, MD. This one year program teaches fellows to provide patient care which is compassionate, appropriate, and effective for the promotion of health, prevention of illness, treatment of disease and care at the end of life.
The Cerebrovascular Research Training Program offers students an opportunity to conduct research in a range of topics including cerebrovascular disease, stroke or pediatric cerebrovascular disorders.